Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, announced today at its Annual Awards Celebration that The Edwards Lifesciences Fund at the Vanguard Charitable Endowment Program plans to grant $4.6 million in 2010 to more than 150 non-profit organizations. This includes $2 million in grants to the University of California, Irvine for the development of The Edwards Lifesciences Center for Advanced Cardiovascular Technology.

"Edwards is dedicated to improving the quality of life around the world by innovating medical technologies that save and protect lives, supporting non-profit organizations through the Fund, and engaging our employees to become involved in their local communities," said Michael A. Mussallem, Edwards Lifesciences' chairman and CEO. "We are proud that the Fund is providing grants to a record number of non-profit organizations this year and that our collective efforts are helping to make a difference."

About Edwards Lifesciences
Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. Driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that enable them to save and enhance lives. Additional company information can be found at www.edwards.com.